09887.HK
Nanjing Leads Biolabs Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 55.75
+0.00%Margins
Gross margin
100.0%
EBITDA margin
-90.0%
EBIT margin
-97.7%
Net margin
-117.3%
FCF margin
0.0%
-29.2%
Return on equity
-17.6%
Return on assets
-17.3%
Return on invested capital
0.15x
Asset turnover
HKD 0.00
Cash from operations
HKD 7.30
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026